Development Level

Tdark 367 | 7,003
Tbio 27 | 10,625
Tchem 13 | 1,890
Tclin 5 | 602

Collection

Eligible Kinase Proteins 2 | 134
Eligible Ion Channel Proteins 1 | 117

IMPC Term

decreased total body fat amoun... 3 | 186
increased circulating alkaline... 3 | 119
preweaning lethality, incomple... 3 | 260
abnormal behavior 2 | 226
decreased lean body mass 2 | 195
increased circulating HDL chol... 2 | 63
increased circulating sodium l... 2 | 71
increased total body fat amoun... 2 | 57
thrombocytopenia 2 | 46
abnormal bone structure 1 | 131
abnormal lens morphology 1 | 73
abnormal retinal blood vessel ... 1 | 18
abnormal sleep behavior 1 | 63
cardiovascular system phenotyp... 1 | 35
decreased body length 1 | 108
decreased bone mineral content 1 | 157
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 77
decreased circulating glucose ... 1 | 121
decreased mean corpuscular hem... 1 | 19
decreased prepulse inhibition 1 | 52
decreased rib number 1 | 59
enlarged thymus 1 | 4
hyperactivity 1 | 108
impaired pupillary reflex 1 | 14
increased circulating choleste... 1 | 53
increased circulating phosphat... 1 | 24
increased circulating potassiu... 1 | 31
increased grip strength 1 | 83
increased mean corpuscular hem... 1 | 93
increased mean corpuscular vol... 1 | 91
increased startle reflex 1 | 38
mydriasis 1 | 9
small kidney 1 | 10
small superior vagus ganglion 1 | 20

Disease

diabetes mellitus 64 | 1,663
medulloblastoma, large-cell 43 | 6,234
osteosarcoma 38 | 7,933
ovarian cancer 33 | 8,484
glioblastoma 23 | 5,572
psoriasis 23 | 6,685
atypical teratoid / rhabdoid tumor 22 | 4,369
Carcinoma 18 | 2,147
adult high grade glioma 17 | 2,148
lung carcinoma 16 | 2,844
primitive neuroectodermal tumor 16 | 3,031
pediatric high grade glioma 15 | 2,712
ependymoma 14 | 2,514
oligodendroglioma 14 | 2,849
Hemolytic anemia 13 | 66
pilocytic astrocytoma 13 | 3,086
Breast cancer 12 | 3,094
lung adenocarcinoma 12 | 2,713
malignant mesothelioma 12 | 3,162
astrocytic glioma 10 | 2,241
colon cancer 10 | 1,475
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
non-small cell lung cancer 10 | 2,798
pituitary cancer 10 | 1,972
Pick disease 9 | 1,893
group 3 medulloblastoma 9 | 2,254
lung cancer 9 | 4,466
non primary Sjogren syndrome sicca 9 | 840
subependymal giant cell astrocytoma 9 | 2,287
ulcerative colitis 9 | 2,087
Rheumatoid Arthritis 8 | 1,160
cystic fibrosis 8 | 1,665
group 4 medulloblastoma 8 | 1,875
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,988
invasive ductal carcinoma 8 | 2,950
sonic hedgehog group medulloblastoma 8 | 1,482
breast carcinoma 7 | 1,614
posterior fossa group B ependymoma 7 | 1,530
non-small cell lung carcinoma 6 | 413
pancreatic cancer 6 | 2,300
astrocytoma 5 | 1,493
ductal carcinoma in situ 5 | 1,745
interstitial cystitis 5 | 2,299
tuberculosis 5 | 1,557
Acquired metabolic disease 4 | 267
Anorexia nervosa 4 | 59
Atrial Fibrillation 4 | 110
Chronic heart failure 4 | 46
Hypertension 4 | 287
Myocardial Perfusion Imaging Adjunct 4 | 25
Platelet Aggregation Inhibition 4 | 22
Prevention of Cerebral Thrombosis 4 | 29
Schizophrenia 4 | 501
Sickle cell anemia 4 | 35
Thalassemia 4 | 46
acute quadriplegic myopathy 4 | 1,157
adrenocortical carcinoma 4 | 1,427
posterior fossa group A ependymoma 4 | 1,511
Blindness 3 | 84
Brain Ischemia 3 | 87
Crohn's disease 3 | 304
Duchenne muscular dystrophy 3 | 602
Malaria 3 | 140
Panic disorder 3 | 55
Retinitis pigmentosa 3 | 153
Schnyder corneal dystrophy 3 | 23
Type 1 diabetes mellitus 3 | 101
active Crohn's disease 3 | 918
atypical teratoid/rhabdoid tumor 3 | 1,095
medulloblastoma 3 | 1,524
nasopharyngeal carcinoma 3 | 1,056
primary pancreatic ductal adenocarcinoma 3 | 1,271
tuberculosis and treatment for 3 months 3 | 327
Alzheimer's disease 2 | 644
Amphetamine-Related Disorders 2 | 74
Amyotrophic Lateral Sclerosis 2 | 431
Atopic dermatitis 2 | 944
Chronic obstructive pulmonary disease 2 | 146
Cocaine-Related Disorders 2 | 88
Down syndrome 2 | 548
Endometriosis 2 | 535
Heart disease 2 | 279
Hypertensive disease 2 | 193
Myocardial Ischemia 2 | 169
Peripheral vascular disease 2 | 90
Seizures 2 | 95
Status Epilepticus 2 | 85
Substance-Related Disorders 2 | 114
Waldenstrons macroglobulinemia 2 | 765
acute myeloid leukemia 2 | 780
dermatomyositis 2 | 933
esophageal adenocarcinoma 2 | 737
head and neck cancer 2 | 270
inflammatory breast cancer 2 | 404
juvenile dermatomyositis 2 | 1,189
non diabetic and post-ischemic heart failure 2 | 200
pancreatic carcinoma 2 | 567
progressive supranuclear palsy 2 | 674
substance-related disorder 2 | 105

Tissue

Female tissues 352 | 18,647
Urinary Tract 329 | 18,444
Endocrine System 271 | 18,512
Nervous System 268 | 18,561
Digestive Tract 249 | 18,473
Skin and soft tissues 217 | 18,115
Liver and Pancreas 160 | 18,136
Blood and immune system 151 | 17,995
Cardiovascular System 141 | 17,958
Male tissues 119 | 17,969
Respiratory system 96 | 17,484

Target Family

oGPCR 373 | 421
Non-IDG 13 | 11,971
Kinase 12 | 634
Enzyme 5 | 4,146
Ion Channel 5 | 341
Transporter 4 | 473

KEGG Pathway

Olfactory transduction 412 | 412
Metabolic pathways 1,254 | 1,254
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Sodium/calcium exchanger 2 SLC8A2 Tbio Transporter -1.56223 31.9 51
Calcium/calmodulin-dependent protein kinase type II subunit alpha CAMK2A Tchem Kinase -1.76384 47.5 542
Olfactory receptor 2T1 OR2T1 Tdark oGPCR 0.00000 38
Beta-arrestin-1 ARRB1 Tchem Non-IDG -2.54226 366.3 416
Olfactory receptor 6B2 OR6B2 Tdark oGPCR 0.00000 1.00 64
Olfactory receptor 13A1 OR13A1 Tdark oGPCR 0.00000 2
Olfactory receptor 5W2 OR5W2 Tdark oGPCR 0.00000 73
Olfactory receptor 5R1 OR5R1 Tdark oGPCR 0.70 0.20 16
Olfactory receptor 10A6 OR10A6 Tdark oGPCR 0.00000 42
Olfactory receptor 13D1 OR13D1 Tdark oGPCR 0.00000 70